30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

RTI and Aziyo Partner on ViBone Cellular Matrix -

RTI Surgical and Aziyo Biologics signed an agreement for RTI's exclusive U.S. distribution of ViBone® cellular bone matrix. Further, the companies will partner on new research for the product. ViBone is a next-gen viable bone matrix designed to perform like high-quality autograft. ViBone is processed using a proprietary method designed to protect and preserve the health of native bone cells, thus potentially enhancing new bone formation. (RTI Surgical, Inc. and Aziyo Biologics, Inc., 8/2/18)